Medical devices, healthcare technology and the business of care
510(k) clearance · K254119

Wearable ECG Recorder (YMHeart XY-12); Wearable ECG Recorder (YMHeart XY-1201); Wearable ECG Recorder (YMHeart XY-1202); Wearable ECG Recorder (YMHeart XY-1203); Wearable ECG Recorder (YMHeart XY-03); Wearable ECG Recorder (YMHeart XY-0301); Wearable ECG Recorder (YMHeart XY-0302); Wearable ECG Recorder (YMHeart XY-0303)

Shenzhen Xinyan Medical Technology Co.,ltd. · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK254119

What did the FDA decide?

On September 11, 2026, FDA recorded a substantially equivalent (SESE) decision for K254119, a traditional 510(k) from Shenzhen Xinyan Medical Technology Co.,ltd. The submission covers the Wearable ECG Recorder under eight YMHeart model designations (XY-12, XY-1201, XY-1202, XY-1203, XY-03, XY-0301, XY-0302, XY-0303), classified as an ambulatory electrocardiograph without analysis under 21 CFR 870.2800, Class II, product codes MWJ and DRG, in the cardiovascular panel. SESE is a clearance to market, not a PMA approval.

The stated indication is to acquire, record and store continuous ECG data as directed by a clinician for patients aged 18 and older, for up to 7 days in hospital, clinic or home settings, with data transferred to PC software over USB. The summary describes a reusable recorder host with a single-use sensor and battery, plus Bluetooth for fit verification. The summary states clinical testing was not needed and cites non-clinical testing; the underlying test data, predicate comparison details and any limitations are not in the provided excerpts.

The public record does not include the full indications enclosure, the predicate's complete labeling, or the performance data supporting equivalence, so independent assessment of those points is not possible from this material.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 11, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254119
Regulatory pathway
510(k) premarket notification
Product code
MWJ
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Electrocardiograph, Ambulatory (Without Analysis).

Product code
MWJ
FDA device class
2

FDA decision timeline

  1. K254119 received

    Application receipt date recorded by FDA.

  2. K254119 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MWJ

Product / regulatory recordCompanyPathwayDecision dateSource
iCOR BeatK260383
iCOR Medical, LLC510(k) clearanceNov 2, 2026FDA
Peerbridge Health, Inc.510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shenzhen Xinyan Medical Technology Co.,ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records